News GlaxoSmithKline S.A.E

Equities

BIOC

EGS38171C012

End-of-day quote Egyptian Exchange Other stock markets 06:00:00 2024-04-21 pm EDT			5-day change	1st Jan Change
31.57 ^EGP	-3.01%		0.00%	-11.20%

Mar. 04	GlaxoSmithKline S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	GlaxoSmithKline S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GlaxoSmithKline S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 04	CI
GlaxoSmithKline S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 18	CI
GlaxoSmithKline S.A.E Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-15	CI
GlaxoSmithKline S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-31	CI
GlaxoSmithKline S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2022	22-06-14	CI
GlaxoSmithKline S.A.E Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-30	CI
GlaxoSmithKline E : Glaxo Smith Kline (BIOC.CA) - Listing Committee Decision	22-03-10	PU
GSK hires former Tesco boss Sir Dave Lewis to head up £40bn spin-off	21-12-20	AQ
GlaxoSmithKline S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
GlaxoSmithKline S.A.E Reports Consolidated Earnings Results for the Six Months Ended June 30, 2021	21-08-11	CI
Glaxosmithkline S.A.E Reports Standalone and Consolidated Financial Results for the Quarter Ended March 31, 2021	21-06-15	CI
Glaxosmithkline S.A.E Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2020	21-03-31	CI
Hikma Pharmaceuticals PLC cancelled the acquisition of GlaxoSmithKline S.A.E.	21-03-10	CI
Glaxo Group Receives Letter from ACDIMA for Acquisition of Glaxosmithkline Shares	21-02-01	CI
Hikma Pharmaceuticals PLC entered into a non-binding term sheet to acquire 91.2% stake in GlaxoSmithKline S.A.E from Glaxo Group Limited.	21-01-25	CI
GlaxoSmithKline S.A.E Reports Audited Standalone Earnings Results for the Year Ended December 31, 2019	20-04-30	CI
GSK Egypt to Launch 2 Production Lines with EGP 100 million Investments	19-11-21	CI
Glaxo Smith Kline Announces Consolidated Earning Results for the Nine Months Ended September 30, 2018	19-09-21	CI
GlaxoSmithKline S.A.E Announces Consolidated and Standalone Earnings Results for the First Quarter Ended March 31, 2018	18-11-26	CI
GlaxoSmithKline S.A.E Announces Consolidated and Standalone Earnings Results for the Six Months Ended June 30, 2018	18-11-26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News GlaxoSmithKline S.A.E

Equities

BIOC

EGS38171C012

Summary

Filters